The physician-patient relationship is a cornerstone of effective medical care. As a gastroenterologist, I have seen firsthand how two central pillars, trust and communication, can unlock potential opportunities for patients to better manage their conditions. One area often overlooked in this relationship is the role clinical trials can play—not just as a path toward new treatments, a last effort therapy or to aid in affordability, but to further develop the relationship between the physician and their patient.
When people think about clinical trials, they often imagine laboratories, data points and the hope of pharmaceutical advancements. While these are crucial, the human element is just as important. For physicians, offering clinical trial opportunities is not only a way to contribute to medical progress but also an avenue to involve patients more deeply in their care journey.
For patients, participation in a trial often is about more than accessing innovative treatments—it is about hope, empowerment and a renewed sense of purpose in their health journey. This provides another avenue to achieve further “patient activation.” Patients with higher activation have proven better equipped to manage their chronic conditions. By inviting patients into this process, we are saying, “You are an active participant in this fight, not a passive recipient.”
One of the most profound ways clinical trials enhance the physician-patient relationship is through communication. Before a patient consents to participate, the conversation is inherently deeper. Physicians must explain the trial’s purpose, potential risks, benefits and unknowns tied together with known data and patient expectations. This transparency builds trust. Patients often feel more valued when they understand their options fully, even if they decide not to participate.
In my practice, I have found that these conversations often extend beyond the trial itself. They open the door to broader discussions about the patient’s goals, fears and values. It is a moment where the clinical side intersects with the personal, fostering a stronger connection.
Clinical trials also shift the dynamic between physician and patient into one of partnership. Patients enrolled in a study are not just following a prescribed treatment plan, they are collaborating with their physician and the broader research community. This collaboration can be empowering, especially for patients with chronic or hard-to-treat conditions, who may otherwise feel limited in their options.
Moreover, the trial process requires regular follow-ups and monitoring, which naturally increases contact between the physician and patient. These touchpoints provide more opportunities to address concerns, monitor progress and adjust care plans. It is in these moments that relationships strengthen, and regardless of if the patient receives placebo, healing can occur.
The world of gastroenterology—and medicine as a whole—is evolving rapidly. New treatments, technologies and insights emerge every year. Clinical trials are at the heart of this progress, but their value goes beyond science. In the end, that connection—the bridge between physician and patient—might just be the most powerful treatment of all.
.jpg?sfvrsn=8b139d5c_1) | Casey Chapman, MD, is the chief medical officer of GI Alliance and an actively practicing gastroenterologist in Baton Rouge, Louisiana. |